Mapping evidence on ovarian, endometrial, vaginal, and vulva cancer research in Africa: a scoping review protocol.
Africa
Endometrial
Epidemiological burden
Gynecological cancer
Ovarian
Rare gynecological neoplasms
Risk factors
Screening techniques
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
14 04 2021
14 04 2021
Historique:
received:
28
09
2020
accepted:
29
03
2021
entrez:
14
4
2021
pubmed:
15
4
2021
medline:
6
7
2021
Statut:
epublish
Résumé
Globally, cancer is generally recognized as a developmental threat yet most countries in Africa lack capacity to diagnose cancer especially gynecological cancers resulting in late detection and poor outcomes. However, most studies on gynecological cancers in Africa tend to focus on cervical cancer compared to the other gynecological cancers. Therefore, this scoping review will aim to describe the existing literature on the epidemiological burden of ovarian, endometrial, vaginal, and vulva cancers, their risk factors, and potential screening methods/techniques in Africa to identify priority research gaps for further research to inform health policy decisions. The framework promulgated by Arksey and O'Malley and improved by Levac et al. will be used as a guide for this scoping review. A comprehensive search for relevant published studies in PubMed, CINAHL, SCOPUS, Google Scholar, and ScienceDirect with no date limitation to the last search date. The database search strategy will include keywords, Boolean operators, and medical subject heading terms. We will additionally consult the WHO/IARC website, IHME/Global Burden of Disease Study. A snowball approach will also be used to search the reference list of all included studies to obtain relevant papers for possible inclusion in this review. We will include articles that involve African countries, focused on ovarian, endometrial, vaginal, and vulva cancers, their risk factors, and potential screening methods/techniques in any language. We will exclude studies on cervical cancer and other cancers as well as review articles. The abstracts and full-text selection will be conducted by two independent reviewers using this review's eligibility criteria as a guide. All the review selection tools, and the data extraction form will be pilot tested for accuracy and consistency. The data will be organized into thematic areas, summarized and the results communicated narratively. It is anticipated that this review will reveal important literature gaps to guide future research to inform health policy decisions about ovarian, endometrial, and rare gynecological neoplasms in Africa. This review's findings will be disseminated via peer review journals, conferences, and other social media such Twitter and LinkedIn.
Sections du résumé
BACKGROUND
Globally, cancer is generally recognized as a developmental threat yet most countries in Africa lack capacity to diagnose cancer especially gynecological cancers resulting in late detection and poor outcomes. However, most studies on gynecological cancers in Africa tend to focus on cervical cancer compared to the other gynecological cancers. Therefore, this scoping review will aim to describe the existing literature on the epidemiological burden of ovarian, endometrial, vaginal, and vulva cancers, their risk factors, and potential screening methods/techniques in Africa to identify priority research gaps for further research to inform health policy decisions.
METHODS
The framework promulgated by Arksey and O'Malley and improved by Levac et al. will be used as a guide for this scoping review. A comprehensive search for relevant published studies in PubMed, CINAHL, SCOPUS, Google Scholar, and ScienceDirect with no date limitation to the last search date. The database search strategy will include keywords, Boolean operators, and medical subject heading terms. We will additionally consult the WHO/IARC website, IHME/Global Burden of Disease Study. A snowball approach will also be used to search the reference list of all included studies to obtain relevant papers for possible inclusion in this review. We will include articles that involve African countries, focused on ovarian, endometrial, vaginal, and vulva cancers, their risk factors, and potential screening methods/techniques in any language. We will exclude studies on cervical cancer and other cancers as well as review articles. The abstracts and full-text selection will be conducted by two independent reviewers using this review's eligibility criteria as a guide. All the review selection tools, and the data extraction form will be pilot tested for accuracy and consistency. The data will be organized into thematic areas, summarized and the results communicated narratively.
DISCUSSION
It is anticipated that this review will reveal important literature gaps to guide future research to inform health policy decisions about ovarian, endometrial, and rare gynecological neoplasms in Africa. This review's findings will be disseminated via peer review journals, conferences, and other social media such Twitter and LinkedIn.
Identifiants
pubmed: 33849664
doi: 10.1186/s13643-021-01654-0
pii: 10.1186/s13643-021-01654-0
pmc: PMC8045365
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108Références
Eur J Surg Oncol. 2006 Oct;32(8):818-24
pubmed: 16684597
Prim Care. 1992 Sep;19(3):607-20
pubmed: 1410066
Clin Nurs Res. 2016 Apr;25(2):115-9
pubmed: 26976609
PLoS One. 2019 Jun 27;14(6):e0218762
pubmed: 31246997
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:37-50
pubmed: 30306580
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Surg Oncol Clin N Am. 1999 Oct;8(4):703-23, vii
pubmed: 10452936
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:14-21
pubmed: 30306589
PLoS One. 2014 Feb 05;9(2):e88323
pubmed: 24505474
BMC Pregnancy Childbirth. 2016 Oct 21;16(1):324
pubmed: 27769193
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:4-13
pubmed: 30306583
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:59-78
pubmed: 30306591
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593